Skip to content
Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence episode artwork

Aug 16, 2018 8 min

Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

from CHI Podcasts Hosted by Cambridge Healthtech Podcasts

Dr. James Trager shares a preview of his talk at the NK cell-based cancer immunotherapy meeting in Boston, discusses his next step in research and the vision of Nkarta in NK cell therapy development and what he’s looking forward to at this meeting such as the topics of inhibition of MIC protein shedding and NK cell metabolism. For more information, please visit http://www.DiscoveryOnTarget.com/NK-Cell-Based-Cancer-Immunotherapy/

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

0:00 8:03

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of CHI Podcasts?

This episode is 8 minutes long.

When was this CHI Podcasts episode published?

This episode was published on August 16, 2018.

Can I download this CHI Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.